Business Models for Pharmacogenetics
This chapter discusses the challenges posed by pharmacogenetics to established "big pharma" business models in the pharmaceutical and diagnostics and device industries. It considers the viability of current business models and the financial incentives of different types of firms.
No Supplementary Data
Document Type: Review Article
Publication date: 2009-11-01